Edwina Raj, Senior Dietician, Aster CMI Hospital Embrace the new heart-healthy nutrition regime to protect our heart. Diet is one of the risk factors
Tag: Cardiovascular
AstraZeneca’s Dapagliflozin (Forxiga) approved in India for treatment of patients with Heart Failure
Dapagliflozin (Forxiga) is the first SGLT-2 inhibitor proven to significantly reduce the risk of Cardiovascular death and hospitalisation for heart failure in patients with